Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04525014
Title RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors (PIRATE)
Acronym PIRATE
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.